Skip to main content
G

Genotrial

Uses AI-powered algorithms to analyze electronic health records and genomic data, rapidly matching cancer patients to suitable clinical trials in minutes. This platform streamlines the trial recruitment process by integrating with EHR systems and genomic databases, reducing the time and cost associated with manual matching. By providing precise, personalized trial recommendations, it expands treatment options and accelerates medical research globally.

Founded 20243300+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Matching cancer patients to relevant clinical trials is a time-consuming and complex process, often relying on manual review of electronic health records (EHR) and genomic data. This manual approach can lead to delays in identifying appropriate trials, limiting patient access to potentially life-saving treatments and slowing down medical research.

Solution

Genotrial offers an AI-powered platform that accelerates the clinical trial matching process for cancer patients. The platform analyzes EHRs and genomic data to rapidly identify suitable trials, significantly reducing the time required for manual matching. By integrating with existing EHR systems and genomic databases, Genotrial streamlines the workflow for healthcare professionals, providing personalized trial recommendations based on a comprehensive analysis of patient data and trial criteria. This enables faster patient enrollment, expands treatment options, and accelerates medical research on a global scale.

Target Audience

The primary target audience includes healthcare professionals, oncologists, clinical trial researchers, and hospitals seeking to improve patient access to clinical trials and accelerate the recruitment process.

Features

  • AI-powered algorithms for rapid analysis of EHRs and genomic data
  • Integration with various electronic health record systems and genomic databases
  • Personalized trial recommendations based on genetic markers, medical history, and trial criteria
  • Oncology Language Learning Model (LLM) for interpreting complex medical terminology
  • Intuitive interface for healthcare professionals to review AI-generated matches
  • Worldwide trial access, connecting patients with clinical trials across the globe
This profile is AI-generated and may contain inaccuracies.